Latest Articles
Stress-Induced Hyperprolactinemia Mimicking Pituitary Pathology: A Diagnostic Challenge - Cureus
Stress-Induced Hyperprolactinemia Mimicking Pituitary Pathology: A Diagnostic Challenge Cureus
Published: June 12, 2025, 7:33 a.m.
Bindi Irwin Reveals Decades of Pain Dismissed by Doctors Before Endometriosis Diagnosis and Emergency Surgery - MSN
Bindi Irwin Reveals Decades of Pain Dismissed by Doctors Before Endometriosis Diagnosis and Emergency Surgery MSN
Published: June 11, 2025, 11:48 p.m.
Study finds childhood adversity linked to elevated risk of endometriosis - Contemporary OB/GYN
Study finds childhood adversity linked to elevated risk of endometriosis Contemporary OB/GYN
Published: June 11, 2025, 7:07 p.m.
Study: Childhood adversity linked to elevated risk of endometriosis - Contemporary Pediatrics
Study: Childhood adversity linked to elevated risk of endometriosis Contemporary Pediatrics
Published: June 11, 2025, 3:05 p.m.
Irish femtech innovator Joii launches AI-powered menstrual monitoring solution - businessplus.ie
Irish femtech innovator Joii launches AI-powered menstrual monitoring solution businessplus.ie
Published: June 11, 2025, 10:03 a.m.
T3-THR Signaling Governed by DIO2 Contributes to Endometrial Receptivity by Regulating Epithelial Cell Membrane Fluidity - Endocrine Society
T3-THR Signaling Governed by DIO2 Contributes to Endometrial Receptivity by Regulating Epithelial Cell Membrane Fluidity Endocrine Society
Published: June 10, 2025, 9:27 a.m.
Nutritional Menopause Support Supplements - Trend Hunter
Nutritional Menopause Support Supplements Trend Hunter
Published: June 10, 2025, 6:32 a.m.
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer - Physician's Weekly
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer Physician's Weekly
Published: June 10, 2025, 6:31 a.m.
Systemic comorbidities in patients with adenomyosis.
How do comorbidities and their prevalence differ between patients with adenomyosis alone and patients with both adenomyosis and endometriosis?
Published: June 10, 2025, midnight
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer - HealthDay
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer HealthDay
Published: June 9, 2025, 2:50 p.m.
Link copied to clipboard!